Compare · OMIC vs RVTY

OMIC vs RVTY

Side-by-side comparison of Singular Genomics Systems Inc. (OMIC) and Revvity Inc. (RVTY): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both OMIC and RVTY operate in Biotechnology: Laboratory Analytical Instruments (Health Care), so they compete in similar markets.
  • RVTY carries a market cap of $17.24B.
  • RVTY has hit the wire 8 times in the past 4 weeks while OMIC has been quiet.
  • RVTY has more recent analyst coverage (24 ratings vs 5 for OMIC).
MetricOMICRVTY
Company
Singular Genomics Systems Inc.
Revvity Inc.
Price
-
-
Market cap
-
$17.24B
1M return
-
-
1Y return
-
-
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ
NYSE
IPO
2021
News (4w)
0
8
Recent ratings
5
24
OMIC

Singular Genomics Systems Inc.

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.

Latest OMIC

Latest RVTY